Recent news on Zanamivir For

New Studies Indicate GSK's Pre-Pandemic Influenza Vaccine Can ...  -  Mar 23, 2007
Drug Newswire (press release),January 2007: GSK begins supplying its antiviral, Relenza(R) (zanamivir for inhalation), to the US government and begins working with private-sector

New Studies Indicate GSK's Pre-pandemic Influenza Vaccine Can ...  -  Mar 12, 2007
Medical News Today (press release),January 2007: GSK begins supplying its antiviral, Relenza® (zanamivir for inhalation), to the USgovernment and begins working with private-sector businesses

Sharp increase of flu in Wales  -  Feb 26, 2007
News Wales,Boards and Trusts on the 8 February recommending the use of the antivirals oseltamivir and zanamivir for the prevention and treatment of influenza,

GlaxoSmithKline Files Its New Pre-Pandemic Influenza Vaccine in Europe  -  Jan 30, 2007
Drug Newswire (press release),...committed over $2 billion to expand capacity for manufacturing flu vaccine and its anti-viral influenza treatment Relenza(R) (zanamivir for inhalation).

GlaxoSmithKline Awarded HHS Contract  -  Nov 30, 2006
Pharmaceutical Online (press release),GSK has supplied its anti-viral, Relenza® (zanamivir for inhalation), to the US government and is now working with private-sector businesses and other

GlaxoSmithKline reaches EU regulatory milestone in its flu pandemic  -  Dec 15, 2006
WebWire (press release),...committed over $2 billion to expand capacity for manufacturing flu vaccine and its anti-viral influenza treatment Relenza® (zanamivir for inhalation).

Flu :: GlaxoSmithKline’s new generation flu vaccine shows a ...  Oct 18, 2006
...recently committed over $2 billion to expand capacity for manufacturing flu vaccine and its anti-viral influenza treatment Relenza® (zanamivir for inhalation ... -SpiritIndia, GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New ...  Oct 9, 2006
...than $2 billion to expand capacity for manufacturing its flu vaccines Fluarix and FluLaval and its antiviral flu medication Relenza(R) (zanamivir for inhalation ... -Drug Newswire (press release), Relenza Approvals Extended in EU  Aug 25, 2006
...today announces that it has received approval from European Regulators in 15 EU countries for use of its anti-viral Relenza® (zanamivir for inhalation) in the ... -PharmaLive.com

15 European Countries Approve Use Of Relenza® In Prevention Of ...  Sep 2, 2006
...today announces that it has received approval from European Regulators in 15 EU countries for use of its anti-viral Relenza ® (zanamivir for inhalation) in ... -Medical News Today

GSK To Supply And Store H5N1 Vaccine Products For US Flu Pandemic ...  -  Nov 23, 2006
Medical News Today (press release),GSK has supplied its anti-viral, Relenza ® (zanamivir for inhalation), to the US government and is now working with private-sector businesses and other

GSK Joins With HHS And CDC To Encourage Flu Vaccinations  -  Nov 14, 2006
Medical News Today (press release),...to expand capacity for manufacturing its flu vaccines Fluarix and FluLaval and its antiviral flu medication Relenza(R) (zanamivir for inhalation).

Relenza Approvals Extended in EU  Aug 25, 2006
...today announces that it has received approval from European Regulators in 15 EU countries for use of its anti-viral Relenza® (zanamivir for inhalation) in the ... -PharmaLive.com

Glaxo's Relenza cleared by EU regulators for influenza A & B ...  Aug 24, 2006
LONDON (AFX) - GlaxoSmithKline PLC said it has received approval from EU regulators for EU-wide use of its anti-viral Relenza -- zanamivir for inhalation -- in ... -Forbes

GlaxoSmithKline Receives Approval in 15 European Countries for Use ...  Aug 25, 2006
...today announces that it has received approval from European Regulators in 15 EU countries for use of its anti-viral Relenza ® (zanamivir for inhalation) in ... -PharmaLive.com

International Approvals: Preotact, Tysabri, Relenza  Jul 10, 2006
The recommended dose of zanamivir for household prophylaxis in patients aged 5 years and older is 10 mg (inhalation of two 5-mg blisters) once daily for 10 days ... -Medscape (subscription)



GlaxoSmithKline Awarded $274 Million HHS Contract; Company to ...  May 4, 2006
...recently committed over $2 billion to expand capacity for manufacturing flu vaccine and its anti-viral influenza treatment Relenza(R) (zanamivir for inhalation ... - Drug Newswire

GSK initiates human trial programme with two H5N1 pandemic flu ...  Apr 20, 2006
...over a billion pounds ($2 billion) to expand capacity for manufacturing flu vaccine and its anti-viral influenza treatment Relenza® (zanamivir for inhalation ... - Vanguard





Relenza approved for flu prevention  Apr 3, 2006
The Food and Drug Administration (FDA) has approved the use of Relenza (zanamivir for inhalation) for prevention of influenza in adults and children 5 years of ... - myDNA.com

FDA approves Relenza to prevent seasonal flu  Mar 30, 2006
The US Food and Drug Administration on March 29 announced its approval of Relenza (zanamivir for inhalation) for PREVENTION of influenza (flu) in adults and ... - Food Consumer

GlaxoSmithKline announces start of clinical trials to test two ...  Mar 30, 2006
...over a billion pounds ($2 billion) to expand capacity for manufacturing flu vaccine and its anti-viral influenza treatment Relenza(R) (zanamivir for inhalation ... - News-Medical.net

Relenza is 2nd drug OK'd to prevent flu  Mar 29, 2006
FDA said in a statement it has approved Relenza (zanamivir for inhalation) as a prophylaxis for flu subtypes A and B in adults and in children 5 years of age ... - United Press International

Second Drug Approved to Prevent Flu  Mar 29, 2006
WEDNESDAY, March 29 (HealthDay News) -- The inhaled antiviral drug Relenza (zanamivir for inhalation) has been approved to prevent influenza in adults and ... - HealthCentral.com

FDA Approves Relenza for Prevention of Seasonal Flu  Mar 30, 2006
ROCKVILLE, Md., March 30 - The FDA, which had already approved Relenza (zanamivir for inhalation) for treatment of seasonal flu, has okayed it for prevention ... - MedPage Today

FDA Approves Relenza For The Prevention Of Influenza A And B In ...  Mar 30, 2006
The Food and Drug Administration (FDA) today approved the use of Relenza (zanamivir for inhalation) for prevention (prophylaxis) of influenza (flu) in adults ... - Medical News Today

FDA Approves a Second Drug for the Prevention of Influenza A and B ...  Mar 29, 2006
BETHESDA, MD -- March 29, 2006 -- The Food & Drug Administration (FDA) today approved the use of Relenza (zanamivir for inhalation) for prevention of influenza ... - DG News

FDA Approves a Second Drug for the Prevention of Influenza A and B ...  Mar 30, 2006
ROCKVILLE, Md., March 29, 2006--The Food and Drug Administration (FDA) today approved the use of Relenza (zanamivir for inhalation) for prevention (prophylaxis ... - PharmaLive.com

GlaxoSmithKline Submits Biologics License Application for FDA ...  Mar 23, 2006
...recently committed over $2 billion to expand capacity for manufacturing flu vaccine and its antiviral influenza treatment Relenza® (zanamivir for inhalation). ... - Yahoo! News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional